Unveiling molecular insights: in silico exploration of TLR4 antagonist for management of dry eye syndrome
Background Dry eye disease is the most commonplace multifractional ocular complication, which has already affected millions of people in the world. It is identified by the excessive buildup of reactive oxygen species, leading to substantial corneal epithelial cell demise and ocular surface inflammat...
Saved in:
Main Authors: | Kothandan Sudhakar, Neeru Dugar, Srikanth Jupudi, Ravichandran Ashwin, Kuppusamy Gowthamarajan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-05-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/9/1/e001610.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reliability of Schirmer and Phenol Red Thread test value on dry eye patients
by: Urvashni Nirghin, et al.
Published: (2025-01-01) -
Associations between dry eye disease and sleep quality: a cross-sectional analysis
by: Anat Galor, et al.
Published: (2024-08-01) -
Extracellular vimentin is a damage-associated molecular pattern protein serving as an agonist of TLR4 in human neutrophils
by: Łukasz Suprewicz, et al.
Published: (2025-02-01) -
Network pharmacology and in silico investigation into the therapeutic potential of phytoconstituents of Peucedanum ostruthium as anti-tubercular agents
by: Neeru Bhanwala, et al.
Published: (2025-03-01) -
Unveiling the flavor and quality variations in dried Zanthoxylum bungeanum maxim from China's diverse regions
by: Xiang Zhu, et al.
Published: (2025-01-01)